Concepedia

Christina Wu

CW

Statistics

Publications

78

Citations

4.8K

H-Index

34

Active since

2010

Affiliations

Emory University(Current)

The Ohio State University

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Mayo Clinic Hospital

Mayo Clinic in Arizona

Christina Wu is an author at Emory University specializing in medicine, oncology, and colorectal cancer.

ORCID

Top concepts

Publications per year

2010–2024

78

Publications

78

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

Al B. Benson, Alan P. Venook, Lynette Cederquist et al. · Journal of the National Comprehensive Cancer Network · 2017 · 1.4K citations · Full text

Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas

Marlo Blazer, Christina Wu, Richard M. Goldberg et al. · Annals of Surgical Oncology · 2014 · 249 citations · Full text

, , +10

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study

John H. Strickler, Andrea Cercek, Salvatore Siena et al. · The Lancet Oncology · 2023 · 217 citations

, , +7

The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapy

Mehmet Asım Bilen, Dylan J. Martini, Yuan Liu et al. · Cancer · 2018 · 157 citations · Full text

Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma

Anne M. Noonan, Matthew R. Farren, Susan Geyer et al. · Molecular Therapy · 2016 · 150 citations · Full text

1–5 of 78